High-dose Ascor IV Vitamin C and oral or buffered Vitamin C supplements are not interchangeable — they operate through different mechanisms, achieve different plasma concentrations, and carry different safety requirements. This guide explains the clinical distinctions, who is and isn't a candidate for IV administration, and what mandatory screening looks like at a physician-supervised infusion center.
TL;DR
- Oral Vitamin C is absorption-limited; plasma concentrations plateau around 200–250 mg/day regardless of dose.
- IV Vitamin C bypasses the gut entirely and can achieve plasma concentrations 30–70x higher than oral supplementation.
- Preservative-free, corn-free Ascor formulation eliminates the sulfite and corn-derived excipient concerns common in standard IV Vitamin C preparations.
- G6PD screening and renal function review are mandatory before high-dose IV administration — not optional.
- Infusion Center of NJ uses Ascor (preservative-free, corn-free) and requires quantitative G6PD and renal screening before every high-dose protocol.
The absorption ceiling that oral Vitamin C can't overcome
Vitamin C (ascorbic acid) is absorbed in the small intestine via sodium-dependent vitamin C transporters (SVCTs). These transporters are saturable — meaning that above a certain oral dose, absorption efficiency drops sharply and the excess is excreted in urine. Clinical studies consistently show that plasma Vitamin C concentrations plateau at approximately 200–250 micromoles per liter regardless of whether you take 500 mg or 10,000 mg orally.
Buffered Vitamin C (ascorbate salts such as calcium ascorbate or sodium ascorbate) improves GI tolerability at higher doses but does not overcome the transporter saturation ceiling. You may experience less GI distress, but you are not achieving meaningfully higher plasma concentrations.
IV Vitamin C bypasses the gut entirely. Administered intravenously, Vitamin C enters the bloodstream directly and can achieve plasma concentrations of 10,000–20,000 micromoles per liter — 30 to 70 times higher than the oral ceiling. This difference in achievable plasma concentration is the central clinical distinction between the two routes.
What "Ascor" means and why formulation matters
Ascor is a pharmaceutical-grade, preservative-free, corn-free IV Vitamin C formulation. Standard IV Vitamin C preparations often contain:
- Sodium bisulfite or sodium metabisulfite — preservatives that can trigger reactions in sulfite-sensitive patients
- Corn-derived ascorbic acid — relevant for patients with corn sensitivities or those following elimination protocols
Ascor eliminates both. For patients with sulfite sensitivity, corn allergy, or those undergoing integrative protocols that restrict corn-derived ingredients, the formulation distinction is clinically meaningful — not a marketing detail.
Infusion Center of NJ uses Ascor exclusively for high-dose IV Vitamin C protocols.
Mandatory pre-infusion screening: G6PD and renal function
High-dose IV Vitamin C is contraindicated in two specific populations, and screening for both is non-negotiable before administration:
G6PD deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked enzyme deficiency that affects red blood cell stability under oxidative stress. High-dose IV Vitamin C generates oxidative metabolites that can trigger hemolytic anemia in G6PD-deficient patients — a serious, potentially life-threatening complication.
Quantitative G6PD testing is required — not qualitative screening. Qualitative tests can miss partial deficiency, particularly in female carriers. A quantitative enzyme activity assay provides the actual G6PD activity level and is the appropriate standard before high-dose IV administration.
Renal function
Vitamin C is metabolized to oxalate. At high IV doses, oxalate load increases substantially, and patients with impaired renal function are at risk for calcium oxalate deposition in renal tubules (oxalate nephropathy). Baseline creatinine and eGFR review is required before initiating a high-dose protocol.
At Infusion Center of NJ, Dr. Jeffrey A. Weiss, MD reviews quantitative G6PD results and renal function labs before every high-dose Ascor IV Vitamin C infusion is scheduled. Patients who have not had recent labs are referred for testing before their first infusion.
Dose ranges and what they mean clinically
IV Vitamin C protocols vary widely in dose:
- Low-dose (7.5–15 g): General wellness, immune support, antioxidant protocols. Lower oxidative stress on red blood cells; G6PD screening still recommended but risk profile is lower.
- Mid-dose (25–50 g): Integrative oncology support, chronic fatigue, post-viral recovery. Quantitative G6PD and renal screening required.
- High-dose (50–100 g): Integrative oncology adjunct protocols, advanced immune modulation. Full screening mandatory; administered over 90–180 minutes with clinical monitoring.
The dose prescribed at Infusion Center of NJ is determined by Dr. Weiss based on the patient's clinical indication, lab results, and treatment goals — not by a menu.
How IV Vitamin C compares to oral and buffered forms: a practical summary
| Oral Vitamin C | Buffered Vitamin C | High-Dose Ascor IV | |
|---|---|---|---|
| Max plasma concentration | ~220 µmol/L | ~220 µmol/L | 10,000–20,000 µmol/L |
| GI tolerability | Variable | Better | Not applicable |
| Preservative-free | Varies | Varies | Yes (Ascor) |
| Corn-free | Varies | Varies | Yes (Ascor) |
| G6PD screening required | No | No | Yes (quantitative) |
| Renal screening required | No | No | Yes |
| Physician order required | No | No | Yes |
Who is a good candidate for high-dose Ascor IV Vitamin C?
Patients who may benefit from a physician consultation about high-dose IV Vitamin C include those with:
- Integrative oncology support needs (adjunct to conventional treatment, not a replacement)
- Chronic fatigue or post-viral immune dysregulation
- Recurrent infections or impaired immune response
- Oxidative stress conditions where oral dosing has been insufficient
- Interest in pre-surgical or post-surgical recovery support
Patients with G6PD deficiency, significant renal impairment, or active kidney stones are generally not candidates for high-dose IV administration.
Scheduling at Infusion Center of NJ
High-dose Ascor IV Vitamin C is available at both the Clifton and Tenafly locations. Patients need a physician consultation and lab review before their first high-dose infusion. The Clifton location at 842 Clifton Avenue, Suite 4 is open seven days a week.
To request a consultation, visit the High-Dose IV Vitamin C page or use the Fast-Track Booking form. Referring physicians can fax orders to (973) 685-2964 — see the physician referral portal for co-management details.
Summary
Oral and buffered Vitamin C are limited by intestinal absorption saturation to plasma concentrations around 220 µmol/L regardless of dose. High-dose Ascor IV Vitamin C bypasses this ceiling entirely, achieving plasma concentrations 30–70x higher. The Ascor formulation eliminates preservative and corn-derived excipient concerns. Mandatory quantitative G6PD and renal screening before high-dose administration is not a formality — it is a clinical safety requirement. At Infusion Center of NJ, every high-dose protocol is physician-ordered, lab-reviewed, and supervised.